ZimVie Inc. announced the U.S. launch of its GenTek Genuine Restorative Components product portfolio on July 23, 2024. The company aims to enhance its prosthetic offerings with this launch, following recent FDA clearance.
Originally launched in Europe in 2019, GenTek has seen significant success in that market. The U.S. introduction brings a broad offering of restorative components to ZimVie’s product family.
“We’re excited to expand our product portfolio with the introduction of GenTek premium prosthetic components, enabling digital workflows and patient-specific restorations for U.S. customers,” said Indraneel Kanaglekar, SVP, Chief Commercial Officer. “We have received excellent feedback and strong demand for GenTek in the European market, and we are optimistic that this product suite will be well received here in the U.S. – the largest market we serve.”
Source: Press Release